Rincian

Repositori :
Publik

Dipublikasi :
21 November 2024 03:21:31

Diperbarui :
21 November 2024 03:32:18

Topik :
Sistem Ketahanan Kesehatan

Sub Topik :
Resiliensi : Vaksin

Unit Kerja :
Sekretariat BKPK

Tipe Dokumen :
Artikel

Versi :
FINAL

Kata Kunci :
Obat Riset Vaksinasi dan imunisasi patogen pneumonia vaksin

20241121_V02_Identifying WHO Global Priority Endemic Pathogens For Vaccine Research And Development (R&D) Using Multi-criteria Decision Analysis (MCDA)- An Objective Of The Immunization Agenda 2030

In five out of six WHO regions, Annual deaths in children under five and Contribution to antimicrobial resistance were the most heavily weighted criteria. How participants weighted the criteria was not associated with their region, biographical characteristics, or areas of expertise. Five pathogens were common priorities across all regions: M tuberculosis, HIV-1, K pneumoniae, S aureus, and Extra-intestinal pathogenic E coli. Six pathogens were priorities in single regions. Combining regional top ten lists provided a global list of 17 priority pathogens for new vaccine R&D. Thirty-four distinct use cases were identified for new products targeting these pathogens. While most are in the “Advance product development” category, ten are in the “Research” category and seven are in the “Prepare to implement” category.